Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial - Publication - Bridge of Knowledge

Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial

Abstract

Citations

3 2 6

CrossRef
0

Web of Science
3 4 6

Scopus

Authors (29)

Michael Wang
Simon Rule
Pier Zinzani
Andre Goy
Olivier Casasnovas
Stephen Smith
Gandhi Damaj
Jeanette Doorduijn
Thierry Lamy
Franck Morschhauser
Carlos Panizo
Bijal Shah
Andrew Davies
Richard Eek
Jehan Dupuis
Eric Jacobsen
Arnon Kater
Steven Le
Lucie Oberic
Taduesz Robak
Todd Covey
Richa Dua
Ahmed Hamdy
Xin Huang
Raquel Izumi
Priti Patel
Wayne Rothbaum
J Slatter
Wojciech Jurczak MD, PhD, Prof

Cite as

Full text

full text is not available in portal

full content of the article see on external site open in new tab

Details

Category:: Magazine publication
Type:: Magazine publication
Published in:: LANCET no. 391, edition 10121, pages 659 - 667,
ISSN: 0140-6736
ISSN:: 0140-6736
Publication year:: 2018
DOI:: Digital Object Identifier (open in new tab) 10.1016/s0140-6736(17)33108-2
Verified by:: No verification

seen 162 times